2025-06-012026-05-312026-05-31falseSC770285V1 HEALTH LIMITED2026-07-03falseiso4217:GBPxbrli:pureSC7702852025-05-31SC7702852026-05-31SC7702852025-06-012026-05-31SC7702852024-05-31SC7702852025-05-31SC7702852024-06-012025-05-31SC770285bus:SmallEntities2025-06-012026-05-31SC770285bus:AuditExempt-NoAccountantsReport2025-06-012026-05-31SC770285bus:FullAccounts2025-06-012026-05-31SC770285bus:PrivateLimitedCompanyLtd2025-06-012026-05-31SC770285core:WithinOneYear2026-05-31SC770285core:AfterOneYear2026-05-31SC770285core:WithinOneYear2025-05-31SC770285core:AfterOneYear2025-05-31SC770285core:ShareCapital2026-05-31SC770285core:SharePremium2026-05-31SC770285core:RevaluationReserve2026-05-31SC770285core:OtherReservesSubtotal2026-05-31SC770285core:RetainedEarningsAccumulatedLosses2026-05-31SC770285core:ShareCapital2025-05-31SC770285core:SharePremium2025-05-31SC770285core:RevaluationReserve2025-05-31SC770285core:OtherReservesSubtotal2025-05-31SC770285core:RetainedEarningsAccumulatedLosses2025-05-31SC770285core:LandBuildings2026-05-31SC770285core:PlantMachinery2026-05-31SC770285core:Vehicles2026-05-31SC770285core:FurnitureFittings2026-05-31SC770285core:OfficeEquipment2026-05-31SC770285core:NetGoodwill2026-05-31SC770285core:IntangibleAssetsOtherThanGoodwill2026-05-31SC770285core:ListedExchangeTraded2026-05-31SC770285core:UnlistedNon-exchangeTraded2026-05-31SC770285core:LandBuildings2025-05-31SC770285core:PlantMachinery2025-05-31SC770285core:Vehicles2025-05-31SC770285core:FurnitureFittings2025-05-31SC770285core:OfficeEquipment2025-05-31SC770285core:NetGoodwill2025-05-31SC770285core:IntangibleAssetsOtherThanGoodwill2025-05-31SC770285core:ListedExchangeTraded2025-05-31SC770285core:UnlistedNon-exchangeTraded2025-05-31SC770285core:LandBuildings2025-06-012026-05-31SC770285core:PlantMachinery2025-06-012026-05-31SC770285core:Vehicles2025-06-012026-05-31SC770285core:FurnitureFittings2025-06-012026-05-31SC770285core:OfficeEquipment2025-06-012026-05-31SC770285core:NetGoodwill2025-06-012026-05-31SC770285core:IntangibleAssetsOtherThanGoodwill2025-06-012026-05-31SC770285core:ListedExchangeTraded2025-06-012026-05-31SC770285core:UnlistedNon-exchangeTraded2025-06-012026-05-31SC770285core:MoreThanFiveYears2025-06-012026-05-31SC770285core:Non-currentFinancialInstruments2026-05-31SC770285core:Non-currentFinancialInstruments2025-05-31SC770285dpl:CostSales2025-06-012026-05-31SC770285dpl:DistributionCosts2025-06-012026-05-31SC770285core:LandBuildings2025-06-012026-05-31SC770285core:PlantMachinery2025-06-012026-05-31SC770285core:Vehicles2025-06-012026-05-31SC770285core:FurnitureFittings2025-06-012026-05-31SC770285core:OfficeEquipment2025-06-012026-05-31SC770285dpl:AdministrativeExpenses2025-06-012026-05-31SC770285core:NetGoodwill2025-06-012026-05-31SC770285core:IntangibleAssetsOtherThanGoodwill2025-06-012026-05-31SC770285dpl:GroupUndertakings2025-06-012026-05-31SC770285dpl:ParticipatingInterests2025-06-012026-05-31SC770285dpl:GroupUndertakingscore:ListedExchangeTraded2025-06-012026-05-31SC770285core:ListedExchangeTraded2025-06-012026-05-31SC770285dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-06-012026-05-31SC770285core:UnlistedNon-exchangeTraded2025-06-012026-05-31SC770285dpl:CostSales2024-06-012025-05-31SC770285dpl:DistributionCosts2024-06-012025-05-31SC770285core:LandBuildings2024-06-012025-05-31SC770285core:PlantMachinery2024-06-012025-05-31SC770285core:Vehicles2024-06-012025-05-31SC770285core:FurnitureFittings2024-06-012025-05-31SC770285core:OfficeEquipment2024-06-012025-05-31SC770285dpl:AdministrativeExpenses2024-06-012025-05-31SC770285core:NetGoodwill2024-06-012025-05-31SC770285core:IntangibleAssetsOtherThanGoodwill2024-06-012025-05-31SC770285dpl:GroupUndertakings2024-06-012025-05-31SC770285dpl:ParticipatingInterests2024-06-012025-05-31SC770285dpl:GroupUndertakingscore:ListedExchangeTraded2024-06-012025-05-31SC770285core:ListedExchangeTraded2024-06-012025-05-31SC770285dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-06-012025-05-31SC770285core:UnlistedNon-exchangeTraded2024-06-012025-05-31SC770285core:NetGoodwill2026-05-31SC770285core:IntangibleAssetsOtherThanGoodwill2026-05-31SC770285core:LandBuildings2026-05-31SC770285core:PlantMachinery2026-05-31SC770285core:Vehicles2026-05-31SC770285core:FurnitureFittings2026-05-31SC770285core:OfficeEquipment2026-05-31SC770285core:AfterOneYear2026-05-31SC770285core:WithinOneYear2026-05-31SC770285core:ListedExchangeTraded2026-05-31SC770285core:UnlistedNon-exchangeTraded2026-05-31SC770285core:ShareCapital2026-05-31SC770285core:SharePremium2026-05-31SC770285core:RevaluationReserve2026-05-31SC770285core:OtherReservesSubtotal2026-05-31SC770285core:RetainedEarningsAccumulatedLosses2026-05-31SC770285core:NetGoodwill2025-05-31SC770285core:IntangibleAssetsOtherThanGoodwill2025-05-31SC770285core:LandBuildings2025-05-31SC770285core:PlantMachinery2025-05-31SC770285core:Vehicles2025-05-31SC770285core:FurnitureFittings2025-05-31SC770285core:OfficeEquipment2025-05-31SC770285core:AfterOneYear2025-05-31SC770285core:WithinOneYear2025-05-31SC770285core:ListedExchangeTraded2025-05-31SC770285core:UnlistedNon-exchangeTraded2025-05-31SC770285core:ShareCapital2025-05-31SC770285core:SharePremium2025-05-31SC770285core:RevaluationReserve2025-05-31SC770285core:OtherReservesSubtotal2025-05-31SC770285core:RetainedEarningsAccumulatedLosses2025-05-31SC770285core:NetGoodwill2024-05-31SC770285core:IntangibleAssetsOtherThanGoodwill2024-05-31SC770285core:LandBuildings2024-05-31SC770285core:PlantMachinery2024-05-31SC770285core:Vehicles2024-05-31SC770285core:FurnitureFittings2024-05-31SC770285core:OfficeEquipment2024-05-31SC770285core:AfterOneYear2024-05-31SC770285core:WithinOneYear2024-05-31SC770285core:ListedExchangeTraded2024-05-31SC770285core:UnlistedNon-exchangeTraded2024-05-31SC770285core:ShareCapital2024-05-31SC770285core:SharePremium2024-05-31SC770285core:RevaluationReserve2024-05-31SC770285core:OtherReservesSubtotal2024-05-31SC770285core:RetainedEarningsAccumulatedLosses2024-05-31SC770285core:AfterOneYear2025-06-012026-05-31SC770285core:WithinOneYear2025-06-012026-05-31SC770285core:Non-currentFinancialInstrumentscore:CostValuation2025-06-012026-05-31SC770285core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-06-012026-05-31SC770285core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-06-012026-05-31SC770285core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-06-012026-05-31SC770285core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-06-012026-05-31SC770285core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-06-012026-05-31SC770285core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-06-012026-05-31SC770285core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-06-012026-05-31SC770285core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-06-012026-05-31SC770285core:Non-currentFinancialInstrumentscore:CostValuation2026-05-31SC770285core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-05-31SC770285core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-05-31SC770285core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-05-31SC770285core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-05-31SC770285core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-05-31SC770285core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2026-05-31SC770285core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-05-31SC770285core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-05-31SC770285core:Non-currentFinancialInstrumentscore:CostValuation2025-05-31SC770285core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-05-31SC770285core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-05-31SC770285core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-05-31SC770285core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-05-31SC770285core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-05-31SC770285core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-05-31SC770285core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-05-31SC770285core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-05-31SC770285bus:Director12025-06-012026-05-31

V1 HEALTH LIMITED

Registered Number
SC770285
(Scotland)

Unaudited Financial Statements for the Year ended
31 May 2026

V1 HEALTH LIMITED
Company Information
for the year from 1 June 2025 to 31 May 2026

Director

WOLL, Raymond David

Registered Address

17/3 Rothesay Terrace
Edinburgh
EH3 7RY

Registered Number

SC770285 (Scotland)
V1 HEALTH LIMITED
Balance Sheet as at
31 May 2026

Notes

2026

2025

£

£

£

£

Current assets
Debtors123,40816,081
Cash at bank and on hand17,9309,869
141,33825,950
Creditors amounts falling due within one year3(121,672)(77,369)
Net current assets (liabilities)19,666(51,419)
Total assets less current liabilities19,666(51,419)
Creditors amounts falling due after one year4(13,406)(13,094)
Net assets6,260(64,513)
Capital and reserves
Called up share capital100100
Profit and loss account6,160(64,613)
Shareholders' funds6,260(64,513)
The financial statements were approved and authorised for issue by the Director on 3 July 2026, and are signed on its behalf by:
WOLL, Raymond David
Director
Registered Company No. SC770285
V1 HEALTH LIMITED
Notes to the Financial Statements
for the year ended 31 May 2026

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
2.Average number of employees

20262025
Average number of employees during the year11
3.Creditors: amounts due within one year

2026

2025

££
Trade creditors / trade payables-2,095
Taxation and social security119,27272,874
Accrued liabilities and deferred income2,4002,400
Total121,67277,369
4.Creditors: amounts due after one year

2026

2025

££
Amounts owed to related parties13,40613,094
Total13,40613,094